Meet Joshua

Biosensor Engineering

Dr. Joshua Sestak currently serves as the Chief Operating Officer of UI Pharmaceuticals.  Most recently he served as the CEO of Orion BioScience, a biotech start-up developing novel autoimmune therapeutics focused on re-establishing tolerance in early-stage patients with autoimmune diseases such as Type-1 Diabetes and Neuromyelitis Optica. Joshua earned his  Ph.D. in Pharmaceutical Chemistry from the University of Kansas and holds a B.S. in Chemistry and Biochemistry from Gonzaga University.